Progression in anti-angiogenesis agents for soft tissue sarcoma
YIN Qiliang
WU Di
YU Yingying
LAN Shijie
Abstract：Soft tissue sarcoma (STS) constitutes a heterogeneous group of rare solid tumors of mesenchymal cell origin with different clinicopathological features.The outcome of patients with advanced STS and the efficacy of chemotherapy are poor.Therefore,new therapeutic strategies are desperately needed to improve treatment efficacy.With deeper understanding of the biological behavior of STS,several emerging anti-angiogenesis agents are used in clinic and have achieved good efficacy,which may bring breakthrough to the treatment of STS and improve the prognosis.In this review,we will discuss the current advances in anti-angiogenesis agents for STS.
Keywords：Soft tissue sarcoma(STS)Anti-angiogenesis agents
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 839-844 )